Physician profile
Daniel Weitz
NPI 1568585289
$21,311.93
in general payments reported to CMS, 2019-2025
19 companies · $2,124 in 2025
The $2,124 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,156 · 2020: $2,431 · 2021: $4,241 · 2022: $3,051 · 2023: $4,243 · 2024: $2,067 · 2025: $2,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,764 · Travel and Lodging: $2,600 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,763.55 |
| Travel and Lodging | $2,600.44 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $10,433.63 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Abbott Laboratories | $3,878.45 | 2019-2025 | Aveir, Confirm Rx, Ensite |
| Medical Device Business Services, INC. | $3,082.22 | 2019-2023 | Carto 3 |
| Medtronic, INC. | $1,613.97 | 2021-2025 | Affera Mapping System, Cobalt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $932.74 | 2019-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Medtronic Vascular, INC. | $401.26 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $320.38 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.51 | 2021-2023 | Lifevest |
| Edwards Lifesciences Corporation | $108.49 | 2023 | |
| Biotronik INC. | $90.66 | 2023 | Acticor 7 Vr-T Dx, Selectra |
| Janssen Pharmaceuticals, INC | $70.91 | 2019-2020 | |
| Amgen INC. | $60.56 | 2019-2020 | |
| Cvrx, INC. | $56.48 | 2023-2024 | Barostim Neo System |
| Cardiva Medical, INC. | $45.70 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Heartflow, INC. | $31.73 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiofocus, INC. | $27.29 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.97 | 2022 | |
| Terumo Medical Corporation | $15.84 | 2021 | |
| Pfizer INC. | $15.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Weitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.